Rare diseases
Investigational molecules
Locations
Back to Portugal658 clinical trials in Loures, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effects of Latozinemab for Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations
PortugalStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
PortugalStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
PortugalStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
PortugalStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
PortugalStudy on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
PortugalStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
PortugalStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
PortugalStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
PortugalStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, particularly exploring new therapies for HER2-positive and hormone receptor-positive variants. Studies include novel combinations of targeted therapies and immunotherapy approaches.
Research includes evaluation of drugs like trastuzumab deruxtecan and combination therapies targeting specific cancer mutations.
Comprehensive studies investigating treatments for multiple sclerosis and neurodegenerative conditions. Research focuses on both relapsing and progressive forms of MS, along with early-stage Alzheimer's disease.
Trials evaluate medications like ocrelizumab and semaglutide for various neurological conditions.
Advanced research into inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Trials evaluate novel therapeutic approaches and combination treatments.
Studies investigate medications such as risankizumab and ozanimod for long-term disease management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
